Table 2.
Social and economic value of the future community pharmacies services
| Potential future services | |||
|---|---|---|---|
| With service | Without service | Difference | |
| Population Covered (n) | 1,724,274 | 1,724,274 | 0 |
| Estimated number of pharmaceutical services (n) | 46,870,802 | 0 | 46,870,802 |
| Time spent in services (hours) | 3,807,870 | 0 | 3,807,870 |
| Social Value | |||
| Quality of Life | |||
| Quality of Life (growth rate, %) | 0.684 | 0.640 | 0.044 (+6.9%) |
| Quality adjusted life years | 1,178,882 | 1,103,242 | 75,640 |
| Health Resource Utilisation (n) | 8,079,565 | 8,443,250 | −363,685 |
| Physician visits (n) | 6,848,352 | 7,211,960 | −363,608 |
| Emergency-room visits (n) | 1,215,835 | 1,215,873 | −38 |
| Hospitalisations (n) | 15,379 | 15,417 | −38 |
| Economic Value | |||
| Total cost (€) | 458.1 M€ | 602.9 M€ | −144.8 M€ |
| Community pharmacy (€) | |||
| Community pharmacist’ service (monetary compensated and non-monetary compensated) | −120.3 M€ | 0 € | −120.3 M€ |
| Patients | 0 € | 0 € | 0 € |
| Cost of Health Resource Utilisation (€) | |||
| Physician visits | 459.0 M€ | 483.3 M€ | −24.4 M€ |
| Emergency-room visits | 87.4 M€ | 87.4 M€ | 0.0 M€ |
| Hospitalisations | 32.1 M€ | 32.2 M€ | −0.1 M€ |
M€, Million euros